Quanterix Corporation 13D and 13G filings for Akoya Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-16 6:00 pm Purchase |
2025-01-09 | 13D | Akoya Biosciences, Inc. AKYA |
Quanterix Corp QTRX |
27,714,011 55.900% |
27,714,011 (New Position) |
Filing |